Midday movers: Lowe's and Zoom rise; Unity Software falls
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/24/2026
- Wall Street ends down as oil prices, Treasury yields rise
- BTIG’s Krinsky warns 2000-like signals are mounting
- HSBC remains max bullish on stocks, tells investors to lean into tech
- Analyst explains why the midterm outcome is a “fundamental non-event”
- Oil settles up around 4% as Iran's president vows to never surrender
- Anthropic's Claude AI identifies novel enzyme system in DNA search
- Wall Street ends down as oil prices, Treasury yields rise
- AppLovin (APP) on watch amid 3% drop premarket as boutique comments circulate
- Plug Power COO resigns to join another company
- Xtend AI Robotics wins Phase III of USSOCOM lethal drone program
TD Cowen Downgrades Macy's (M) to Market Perform, 'Prudent Bold New Changes Will Take Time to Drive Upside to Guidance'
February 29, 2024 5:29 AM ESTTD Cowen analyst Oliver Chen downgraded Macy's (NYSE: M) from Outperform to Market Perform with a price target of $20.00 (from $23.00).
The analyst comments "We like changes ahead including 150 Macy's closures, store growth across luxury (+30 Bluemercury & +15 Bloomies) and small format (+30), and private label and inventory... More
Macy's (M) PT Raised to $22 at Citi, 'We Lean More Positive but Stay Neutral'
February 28, 2024 3:19 AM ESTCiti analyst Paul Lejuez raised the price target on Macy's (NYSE: M) to $22.00 (from $18.00) while maintaining a Neutral rating.
The analyst comments "4Q GM/EPS beat consensus though sales were still weak (comps -5%) and mgmt is looking for a sales decline in... More
CFRA Downgrades Macy's (M) to Hold
February 27, 2024 12:55 PM ESTCFRA analyst Zachary Warring downgraded Macy's (NYSE: M) from Buy to Hold with a price target of $18.00 (from $19.00).
The analyst comments "We lower our 12-month price target by $1 to $18, based on 7.2x our FY 25 (Jan.) EPS estimate and in line with the company's... More
Viking Therapeutic (VKTX) PT Raised to $80 at Stifel, '“Best-in-Class” Profile of Injectable VK2735 Stands Firm'
February 27, 2024 12:06 PM ESTStifel analyst Samimy Annabel raised the price target on Viking Therapeutic (NASDAQ: VKTX) to $80.00 (from $35.00) while maintaining a Buy rating.
The analyst comments "Ahead of schedule, VKTX released the Ph.2 VENTURE data for injectable-VK2735, which again demonstrated a highly competitive profile relative to... More
AutoZone (AZO) PT Raised to $3,200 at CFRA, 'We...like AZO's robust international growth'
February 27, 2024 12:04 PM ESTCFRA analyst Garrett Nelson raised the price target on AutoZone (NYSE: AZO) to $3,200.00 (from $3,000.00) while maintaining a Buy rating.
The analyst comments "We lift our 12-month target to $3,200 from $3,000, based on a FY 25 (Aug.) P/E of 19.0x, a premium to... More
